Non-Hodgkin's Lymphoma — Selection of Treatment on the Basis of Histologic Type

Abstract

THE management of patients with malignant lymphomas has undergone considerable change during the past 10 years. As a result of advances in diagnostic and therapeutic methods, treatment results have dramatically improved for patients with Hodgkin's disease.^{1 , 2} The situation is not the same for patients with lymphomas other than Hodgkin's disease, the so-called non-Hodgkin's lymphomas.³ Problems in this field are reflected by the continued proposals of new histopathologic classifications and nomenclature.^{4 5 6 7} In part, this is due to new knowledge and concepts of the function of the lymphoid system. However, the search for new classifications and clinico-pathologic correlations is also motivated by . . .